These results suggest that PIR may facilitate tumor survival by inhibiting FAS‐NIK‐NFκB2‐FAS positive feedback loop of FAS expression and FAS‐mediated cell death in colon cancers. Here, NFKB2 is linked to malignant colon neoplasm.